IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 192 filers reported holding IMMUNITYBIO INC in Q2 2024. The put-call ratio across all filers is 2.89 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $647,640 | +124.7% | 102,475 | +90.9% | 0.00% | – |
| Q1 2024 | $288,287 | +11.8% | 53,685 | +4.5% | 0.00% | – |
| Q4 2023 | $257,786 | +285.6% | 51,352 | +29.8% | 0.00% | – |
| Q3 2023 | $66,847 | -62.4% | 39,554 | -38.2% | 0.00% | – |
| Q2 2023 | $177,789 | +195.1% | 63,953 | +93.2% | 0.00% | – |
| Q1 2023 | $60,247 | -17.2% | 33,103 | +130.6% | 0.00% | – |
| Q4 2022 | $72,769 | -21.8% | 14,353 | -23.2% | 0.00% | – |
| Q3 2022 | $93,000 | +52.5% | 18,700 | +15.2% | 0.00% | – |
| Q2 2022 | $61,000 | -91.8% | 16,237 | -87.8% | 0.00% | – |
| Q1 2022 | $748,000 | -0.5% | 133,280 | +7.8% | 0.00% | – |
| Q4 2021 | $752,000 | -38.4% | 123,636 | -1.3% | 0.00% | – |
| Q3 2021 | $1,220,000 | -47.0% | 125,207 | -22.4% | 0.00% | -100.0% |
| Q2 2021 | $2,304,000 | +88.5% | 161,367 | +213.5% | 0.00% | – |
| Q1 2021 | $1,222,000 | – | 51,467 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |